What is NovoCure's total liabilities?

NovoCure (NVCR) reported total liabilities of $457.21M in Q1 2026.

How has NovoCure's total liabilities changed year-over-year?

NovoCure's total liabilities decreased by 48.4% year-over-year, from $886.85M to $457.21M.

What is the long-term trend for NovoCure's total liabilities?

Over 5 years (2020 to 2025), NovoCure's total liabilities has grown at a -4.2% compound annual growth rate (CAGR), from $575.46M to $463.86M.

What does total liabilities mean?

The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.

NovoCure NVCR Total Liabilities

Total Liabilities at other companies

MedtronicMDT

$42.96B-1.1%

Iovance Biotherapeutics, Inc.IOVA

$203.91M+2.5%

Nuvation BioNUVB

$290.68M+298%

Vir Biotechnology, Inc.VIR

$212.82M-19.4%

Syndax PharmaceuticalsSNDX

$431.05M+1.3%

Boston ScientificBSX

——

Other financials

Income statement

See full

Revenue$174.1M+12.3%

Gross profit$135.1M+16.0%

Operating income-$67.4M-78.1%

Net income-$71.1M-107%

EPS (diluted)-$0.62-100%

Balance sheet

See full

Cash & equivalents$87.5M-31.2%

Total debt$39.5M-2.1%

Total equity$330.7M-8.6%

Total assets$787.9M-36.9%

Cash flow

See full

Operating cash flow-$13.5M+62.1%

CapEx$5.2M-51.4%

Free cash flow-$18.7M+59.7%

Valuation

See full

Market cap$1.7B-36.7%

Enterprise value$1.66B-36.3%

P/S2.5×-1.8×

Profitability

See full

Gross margin75.2%-2.0pp

Operating margin-27.2%+0.4pp

Net margin-25.7%-0.7pp

FCF margin-7.1%-2.0pp

Returns & leverage

See full

Return on equity-50%+5.4pp

Debt / equity0.1×0.0×

Current ratio2.9×+1.4×

Where this comes from

Reported directly by NovoCure in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about NovoCure's total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NovoCure's total liabilities?: NovoCure (NVCR) reported total liabilities of $457.21M in Q1 2026.
How has NovoCure's total liabilities changed year-over-year?: NovoCure's total liabilities decreased by 48.4% year-over-year, from $886.85M to $457.21M.
What is the long-term trend for NovoCure's total liabilities?: Over 5 years (2020 to 2025), NovoCure's total liabilities has grown at a -4.2% compound annual growth rate (CAGR), from $575.46M to $463.86M.
What does total liabilities mean?: The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.